Alafair Biosciences Returns to Vizient Innovative Technology Exchange to Showcase VersaWrap Hydrogel Sheet
Alafair Biosciences is thrilled to announce its return to the Vizient Innovative Technology Exchange, taking place on September 18th in Las Vegas. This marks the second consecutive year that Alafair has been selected to showcase its groundbreaking product, VersaWrap Hydrogel Sheet (VersaWrap), at this prestigious event hosted by Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company.
VersaWrap is a game-changer in the realm of surgical care, featuring a unique blend of hyaluronic acid (HA) and alginate. This advanced hydrogel technology facilitates smooth tissue gliding and minimizes tethering, which can significantly reduce the need for reoperations and enhance patient outcomes. Unlike many competing products, which are collagen-based and may add bulk, VersaWrap is made from plant-based materials and dissolves completely, avoiding any bulk or additional tissue formation.
The Innovative Technology Exchange offers a prime platform for selected suppliers to present their innovations to leading supply chain and clinical experts from Vizient’s network of customer hospitals. These experts evaluate how each product or service can advance clinical outcomes, improve safety, or drive efficiency in healthcare delivery.
“We are honored to participate once again in the Vizient Innovative Technology Exchange,” said John Joyoprayitno, co-founder, president, and CEO of Alafair Biosciences. “Our continued selection by Vizient highlights the transformative impact of VersaWrap in surgical care. We’re excited to demonstrate how our technology is making a difference in patient outcomes and healthcare practices.”
The exchange is part of Vizient’s broader Innovative Technology Program, which rigorously reviews supplier-submitted technologies through member-led councils and task forces. Since its inception in 2003, Vizient has evaluated over 1,600 product submissions.
About Alafair Biosciences, Inc.
Alafair Biosciences is a leading innovator in medical device technology, specializing in hydrogel products designed to revolutionize surgical care. The company’s mission is to enhance patient outcomes and surgical precision with its versatile hydrogel technology. Alafair’s products are distributed through a wide network of independent distributors across the United States.
About VersaWrap Hydrogel Sheet
VersaWrap is an FDA-cleared medical device made from a blend of hyaluronic acid and alginate, designed to provide a protective, gelatinous encasement for peripheral nerves, tendons, ligaments, and skeletal muscles. This innovative technology allows for seamless tissue movement, reducing the risk of reoperations and improving overall patient recovery.
For more information, please visit Alafair Biosciences.
